Articles by Kenneth I. Kaitin - Pharmaceutical Executive

ADVERTISEMENT

Articles by Kenneth I. Kaitin

Kenneth I. Kaitin


Opinion: Memo to von Eschenbach
January 1, 2006

Often, post-approval marketing studies don't materialize because drug companies question their value. Independent review of the need for such studies would address pharma's concern that they may be warranted.

ADVERTISEMENT

Click here